NCT06168682View on ClinicalTrials.gov

Nasal CPAP - The Treatment IMpact on Oxygenation in High-risk Patients During Deep Sedation for Endoscopy

NACompletedINTERVENTIONAL

Enrollment

158

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

May 30, 2024

Study Completion Date

June 30, 2024

Conditions

Continuous Positive Airway PressureEndoscopyOxygenationObesity

Interventions

DEVICE

SuperNO2VA™ Et by Vyaire Medical, Inc.

SuperNO2VA™ Et provides a nCPAP between 3 to 10 cmH20 using a oxygenflowrate of 6l/O2

DEVICE

nasal oxygen cannula

Standard Operating Procedure (SOP) for endoscopy: Using a nasal oxygen cannula with oxygenflowrate of 6l/O2

Trial Locations (1)

20246

Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, Hamburg

All Listed Sponsors

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT06168682 - Nasal CPAP - The Treatment IMpact on Oxygenation in High-risk Patients During Deep Sedation for Endoscopy | Biotech Hunter | Biotech Hunter